BioWorld MedTech

Oct. 7, 2013

OrthoSensor in plan to market Verasense OUS

Coming off a successful approval from the FDA, OrthoSensor (Dania Beach, Florida) reported that it has received CE mark approval for its Verasense Knee System, and plans to launch the device in the European markets. Read More

Washington roundup: FDA sees 2% treatment effect from nurses in Champion trial

Report from Europe: Spire helps launch Elekta radiotherapy service in UK

Report from Asia: Unusual patent probe is seen targeting Chinese device maker

Deals roundup: Crestview Acquisition in plan to acquire GMT

Ultrasound may simplify prostate cancer screening

Restructuring roundup: Echo implements cost reduction measures

Med-Tech Notes

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...